Compare Cassava Sciences Inc (FLNA) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Star Bulk Carriers Corp — how do they compare? Cassava Sciences Inc trades at $0.82 (market cap $39.40M), while Star Bulk Carriers Corp trades at $30.28 (market cap $3.54B). The key difference: Star Bulk Carriers Corp is far larger — about 89.8× Cassava Sciences Inc's market cap, and Star Bulk Carriers Corp pays a 6.17% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and Star Bulk Carriers Corp for 24 Days on average.
| FLNA | SBLK | |
|---|---|---|
Market Cap | $39.40M | $3.54B |
Volume | 759,018 | 1,437,622 |
Sector | Health | Industrials |
52-Week High | $4.64 | $32.49 |
52-Week Low | $0.68 | $16.79 |
Typical Hold Time | 37 Days | 24 Days |
Enterprise Value | -$43.28M | $4.22B |
Dividend Yield | — | 6.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.8157, down 6.77% today, with a bearish technical signal from moving averages. The company shows improving quarterly EPS trends, beating expectations in recent quarters, though it remains unprofitable with negative ROE and ROA. Recent FDA clearance for its epilepsy drug trial provides a positive catalyst. Analyst sentiment is bullish with 67% buy ratings.
The outlook hinges on clinical progress; upside exists if Phase 2a trials succeed, but high cash burn and lack of revenue pose significant risks. Investors should weigh the strong analyst support against the company's financial challenges and binary clinical outcomes.
Star Bulk Carriers (SBLK) trades at $29.69, down 0.57% on the day, with a bearish technical signal despite strong fundamental performance. The company delivered three consecutive earnings beats, with Q2 2026 EPS of $1.21 exceeding expectations by 27%. Revenue grew 45% year-over-year, and management maintains a 100% free cash flow distribution policy, recently declaring a $0.90 dividend payable September 3, 2026.
SBLK presents a compelling value opportunity with attractive valuation metrics (P/E 11.95, P/S 2.86) and strong profitability (23.87% net margin). Analyst consensus leans bullish (58% buy ratings), but technical weakness and shipping market volatility pose near-term risks. The stock's 61% annual gain reflects strong operational execution, though current price action suggests consolidation after recent highs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
